InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,658.71
(
1.22%
)
Post# of 251707
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: DonShimoda post# 154924

Saturday, 01/05/2013 9:49:51 AM

Saturday, January 05, 2013 9:49:51 AM

Post# of 251707
XOMA -- Current Clinical Trials

Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis (EYEGUARD™-A)
http://clinicaltrials.gov/ct2/show/NCT01684345?term=xoma&rank=11

Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment (EYEGUARD™-C)
http://clinicaltrials.gov/ct2/show/NCT01747538?term=xoma&rank=10

Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
http://clinicaltrials.gov/ct2/show/NCT01498874?term=xoma&rank=15

Safety and Biologic Activity Study of Gevokizumab to Treat Erosive Osteoarthritis of the Hand
http://clinicaltrials.gov/ct2/show/NCT01683396?term=xoma&rank=17
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up